Vanda Pharmaceuticals buy BiotechBee
Start price
24.12.23
/
60%
€3.70
Target price
31.08.25
€5.00
Performance (%)
20.00%
End price
14.12.24
€4.44
Summary
This prediction ended on 14.12.24 with a price of €4.44. The prediction had a final performance of 20.00%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | -1.674% | -1.674% | 16.287% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
According to BiotechBee what are the pros and cons of Vanda Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year